Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Jan 20;2(2):143–152. doi: 10.1158/1940-6207.CAPR-08-0099

Fig. 4.

Fig. 4

Effects of γ-TmT treatment on plasma or colonic levels of PGE2, LTB4, 8-isoprostane, and nitrotyrosine. A, PGE2, LTB4, and 8-isoprostane levels were determined in the plasma of AOM/DSS–treated mice (on day 3, day 7, and week 7) and DSS-treated mice (on days 3 and 7). B, PGE2, LTB4, and nitrotyrosine levels were determined in the colon (homogenates) of AOM/DSS–treated mice. Columns, mean of group (n = 9–10 per AOM/DSS–treated group; n = 4–5 per DSS-treated group); bars, SE. Different superscripts (a, b, c, d) indicate statistical difference among levels of AOM/DSS–treated mice (by one-way ANOVA; P < 0.05). Statistical difference between levels of the γ-TmT–treated and the respective control group: **, P < 0.05 by the two-tailed t test; *, P < 0.05 by the one-tailed t test (P = 0.07 by two-tailed t test).